Zena Pharm | The Board
page-template,page-template-full_width,page-template-full_width-php,page,page-id-58,mkd-core-1.0.4,ajax_leftright,page_not_loaded,,mkd-theme-ver-1.10,smooth_scroll,wpb-js-composer js-comp-ver-5.2.1,vc_responsive

Mr. Jeremy Delk


Mr. Delk has been a successful entrepreneur for over a decade, with a keen eye for innovative new products, technologies and unexploited market niches. Mr. Delk utilized the financial acumen he learned in the financial sector with Fidelity Investments, while working in both Boston and NYC, to incorporate Delk Enterprises in 2001. With the growth of Delk Enterprises, Mr. Delk made the decision to move back to his native Kentucky focusing on the growth of his company.


Over time, Mr. Delk expanded Delk Enterprises from primarily a real estate holdings firm to a diversified private equity portfolio including equity holdings in animal health, sports medicine, human health care, pharmacy & creating access to future IP through project funding in the technology and human health R&D initiatives.

In addition to his businesses, Mr. Delk primary passion lies in the thoroughbred racing industry. Mr. Delk family history in the equine industry spans over four decades highlighted in 1978 when his grandfather’s horse, Special Honor, competed in the Kentucky Derby against Affirmed and Alydar. In 2008 while seeking alternative solutions for his own racing stable Mr. Delk discovered MediVet, an Australian firm involved in cutting edge stemcell technology. His foresight and acumen to seek out underserved markets led to the incorporation of MediVet America LLC a Lexington, KY based company.

Mr. Mark Linford

Technical Advisor

Mr. Linford has a diverse business background stretching over 34 years, and has always been at the forefront of new technologies. A previous business owner in industries as diverse as plastic fabrication and sanitation chemicals, one of his major achievements was the launch of a leading topical pain relief product into the Pharmacy and Medical field. Launching The Elmore Oil Company in September 2004, the product by the same name, Elmore Oil, became Australias fastest growing topical pain relief product in 2007, jumping from 18th to 5th place in its category. By 2012 Elmore Oil was positioned 4th overall in its category, and the Number 1 natural topical pain reliever in Australia, with exports to 12 countries. This brand was licensed out in 2013.


In 2006, during the ongoing development of the Elmore Oil Company, he created the Future Champions Program – a scholarship program to assist aspiring young athletes in their quest to reach their ultimate dreams. The Elmore Oil Company partnered with Australia’s Premier Educational based Charity Organisation, The Smith Family, to bring the Future Champions Program to fruition.

In 2009, furthering his philanthropic interests, Mr Linford then developed the Elmore Trust Fund for Street Children in the Philippines, to assist children from impoverished backgrounds at the grass roots level. This program, later renamed The Future Kids Program, still operates today and staff deliver food parcels to thousands of families across the Philippines on a regular basis.


Mr. Linford is currently also a shareholder and board member of Pain Away LLC, a US based distributor of pain relief and skin care products to the pharmacy and sports market in the USA. He is the CEO of Regenex Laboratories, a global supplements manufacturer and a strategic advisor to Enhanced Shockwave Solutions, Australia’s No 1 distributor of Shockwave and Acoustic Wave medical therapy equipment.


He is a former published author, writing for business and marketing magazines, a mentor for the Australian Business Development Centre and a former board member of the CVBN, Central Victoria’s premier business network. In 2016 Mr. Linford was made a Fellow of the Australian Institute of Management (FAIM), which recognises his outstanding management skills.

Mr. Garry Andrews


Mr Andrews has extensive senior level executive experience, with a focus on brand development and marketing. He is currently the CEO of AECS Global, one of the worlds leading animal health supply companies.


Mr Andrews was previously the co-founder of Medivet Pty Ltd, the world’s largest Veterinary Supply and Regenerative Stem Cell Company, specialising in in-clinic Stem Cell Therapy for animals suffering degenerative conditions.


Medivet has achieved distribution in over 36 countries and works with clients from the largest stables in the world, including the ruling families of the UAE and

Middle East Region. In December 2013, Medivet Pty Ltd was formally acquired by Medical Australia Limited.


Mr Andrews is also a co-founder, and majority shareholder of Tailor Made Equine a marketing company for Animal Health Products. With 2 distinct divisions, human health & animal health, Taylor made develops products as diverse as DNA sequencing, anti-aging compounds, beauty products and veterinary compounds.

Professor Don Cohen

Chief Scientific Advisor

Professor Cohen holds a Bachelor of Science in Biological Sciences from the University of Cincinnati, OH, (1972) and is a Doctor of Philosophy in Microbiology from the University of Cincinnati, OH, 1979.


Professor Cohen was a research fellow in cancer immunology for the Virginia Commonwealth University Medical College of Virginia in Microbiology/Immunology from 1979 through February, 1982.


Currently a Professor of Microbiology, Immunology and Molecular Genetics at the College of Medicine, University of Kentucky, USA. He also holds a joint appointment at the Graduate Centre for Toxicology, is Scientific Director of the Flo Cytometry Facility, and is a member of the Lucille Parker Markey Cancer Centre at the University of Kentucky.

Professor Cohen is a member of the Professional Association of Immunologists, a member of the Society for Leucocyte Biology and a member of the International Cytokine Society. He is often invited to sit on peak industry bodies and committees and is a published author for the Journal of Leukocyte Biology, the Journal of Immunology, the Journal of Clinical Investigation, the Journal of Endocrinology and the American Journal of Pathology.


By invitation he has presented medical research papers at over 20 conferences, both in the USA and around the world on topics as diverse as HIV, T Cell Activation, Immunology and treatment of Melanoma.